Purinergic signaling and vascular cell proliferation and death

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 3, 2002, Pages 364-373

  Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apoptosis; Atherosclerosis; ATP; Proliferation; Purinergic signaling

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PURINE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIMIDINE;

ARTERY OCCLUSION; ATHEROSCLEROSIS; CELL DEATH; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; ISCHEMIA; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; THROMBOCYTE; VASCULAR SMOOTH MUSCLE;

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CELL DIVISION; ENDOTHELIUM, VASCULAR; HUMANS; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; URIDINE TRIPHOSPHATE; VASCULAR DISEASES;

EID: 0036118418     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0302.105360     Document Type: Short Survey

References (150)

1. The past, present and future of purine nucleotides as signalling molecules
2. A basis for distinguishing two types of purinergic receptor
3. Receptors for purines and pyrimidines
4. Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors
5. Purinergic stimulation of cell division and differentiation: Mechanisms and pharmacological implications
6. P1 and P2 receptors in cell growth and differentiation
7. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells
8. Purinergic signalling: Pathophysiological roles
9. Dual control of local blood flow by purines
10. Cardiovascular purinoceptors
11. 2-purinoceptors in the cardiovascular system
12. New insights into the local regulation of blood flow by perivascular nerves and endothelium
13. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction
14. Roles of purines and pyrimidines in endothelium
15. Endothelium and smooth muscle: Trophic interactions and potential for therapeutic intervention
16. The pathogenesis of atherosclerosis: A perspective for the 1990s
17. Autocrine-paracrine factors and vascular remodeling in hypertension
18. Extracellular ATP: A growth factor for vascular smooth muscle cells
19. The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors
20. Trophic roles of purines and pyrimidines
21. Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells
22. Adenosine inhibits growth of rat aortic smooth muscle cells: Possible role of A2b receptor
23. Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury
24. The smooth muscle cell in culture
25. 2B receptors
26. Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells
27. Sodium butyrate is a potent modulator of smooth muscle cell proliferation and gene expression
28. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells
29. Stimulation of prostaglandin biosynthesis by adenine nucleotides: Profile of prostaglandin release by perfused organs
30. Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells
31. 1 phase in vascular smooth muscle cells in primary culture
32. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels
33. Tropic interactions between sympathetic nerves and vascular smooth muscle
34. Influence of adrenergic innervation on vascular growth and mature characteristics
35. Noradrenaline and ATP as cotransmitters in sympathetic nerves
36. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters
37. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells
38. Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells
39. 4 nucleotide receptor
40. 4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP
41. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR
42. 2 receptors in vascular smooth muscle cells
43. Chemotactic mitogenic, and angiogenic actions of UTP on vascular endothelial cells
44. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes
45. Antiproliferative effect of UTP on human arterial and venous smooth muscle cells
46. Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells
47. ATP-stimulated release of ATP by human endothelial cells
48. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate
49. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: Cooperation with noradrenaline and ATP
50. Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth
51. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells
52. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways
53. Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells
54. The small GTPase Rho: Cellular functions and signal transduction
55. Rho GTPases and signaling networks
56. Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis
57. 2 receptors and increased mitogenic responses to UTP and ATP
58. Model system to study interaction of platelets with damaged arterial wall, II: Inhibition of smooth muscle cell proliferation by dipyridamole and AH-P719
59. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane
60. Vascular development in chick embryos: A possible role for adenosine
61. Angiogenesis in skeletal and cardiac muscle
62. Increased flow-induced ATP release from isolated vascular endothelial but not smooth muscle cells
63. Purinergic signalling: ATP release
64. Local application of adenosine induces an increase of capillary diameter in skeletal muscle of anesthetized rabbits
65. Effects of adenine nucleotides on the proliferation of aortic endothelial cells
66. The effect of vasoactive factors on the growth of coronary endothelial cells
67. Adenosine stimulates proliferation of human endothelial cells in culture
68. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation
69. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors
70. Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells
71. Adenosine stimulation of DNA synthesis in human endothelial cells
72. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells
73. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine
74. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells
75. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells
76. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation
77. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells
78. Angiogenic potency of nucleotide metabolites: Potential role in ischemia-induced vascular growth
79. Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells
80. Angiogenic factors and their assay: Activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper, and bovine endothelium stimulating factor
81. Adenosine nucleotides, adenosine and adenine as angiogenesis factors
82. Mitogenic action of adenine nucleotides and nucleosides on aortic endothelial cells
83. Purinoceptor-mediated calcium mobilization and cellular proliferation in cultured bovine corneal endothelial cells
84. Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agents
85. Modulation of vascular smooth muscle contraction by the endothelium
86. Chronic in vitro flow promotes ultrastructural differentiation of endothelial cells
87. How do injured cells communicate with the surviving cell monolayer?
88. 2+ rather than of cAMP
89. Involvement of multiple receptors in the actions of extracellular ATP the example of vascular endothelial cells
90. P2X receptors counteract the vasodilatory effects of endothelium derived hyperpolarising factor
91. 2x (purinergic) receptor distributions in rat blood vessels
92. 4 purinoceptors
93. 2 receptor immunoreactivity in vascular endothelial cells in rat brain
94. Immunohistochemical identification of cells expressing ATP-gated cation channels (P2X receptors) in the adult rat thyroid
95. Stimulation by the nucleotides, ATP and UTP of mitogen-activated protein kinase in EAhy 926 endothelial cells
96. 2+, phospholipase C and mitogen-activated protein kinase
97. P2Y receptor-mediated inhibition of tumor necrosis factor alpha-stimulated stress-activated protein kinase activity in EAhy926 endothelial cells
98. Apoptosis in the vasculature: Mechanisms and functional importance
99. MAPK cascades in cell growth and death
100. Dr. Jekyll/Mr. Hyde: The dual role of extracellular ATP
101. 7 receptors by immunohistochemistry in rat stratified squamous epithelia
102. P2X receptors in the rat duodenal villus
103. Extracellular ATP as a trigger for apoptosis or programmed cell death
104. Cell membrane receptors for extracellular ATP a new family of apoptosis-signalling molecules
105. Adenosine-induced cell death: Evidence for receptor-mediated signalling
106. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells
107. The effect of pyrimidine nucleosides on adenosine-induced apoptosis in HL-60 cells
108. Mechanism of extraceflular ATP- and adenosine-induced apoptosis of cultured pulmonary artery endothelial cells
109. ATP converts necrosis to apoptosis in oxidant-injured endothelial cells
110. The biochemistry of programmed cell death
111. Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis
112. Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65
113. Population dynamics of arterial smooth muscle cells, V: Cell proliferation and cell death during initial 3 months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimal trauma
114. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
115. Angiogenesis
116. Chronic oral dipyridamole as a "novel" antianginal drug: The collateral hypothesis
117. European Stroke Prevention Study, 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
118. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells
119. Effect of hypercholesterolemia on vascular reactivity in the rabbit, I: Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits
120. Segmental impairment of endothelium-mediated relaxation in thoracic aortas from atherosclerotic rabbits: Comparison to cholesterol infiltration and energy metabolism
121. Release of endogenous ATP from the caudal artery in rats with arteriosclerosis
122. Long-term supplementation with a high cholesterol diet decreases the release of ATP from the caudal artery in aged rats
123. Dual control by nerves, endothelial cells of arterial blood flow in atherosclerosis
124. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
125. The effects of intracoronary adenosine on preconditioning during coronary angioplasty
126. Preconditioning of human myocardium with adenosine during coronary angioplasty
127. Smooth muscle proliferation in hypertension: State-of-the-art lecture
128. Sympathetic overactivity in hypertension: A moving target
129. Differential effects of α β-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries
130. Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats
131. Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats
132. Altered regulation of nerve growth factor secretion by cultured VSMCs from hypertensive rats
133. The pericyte: A review
134. Growth factors and pericytes in microangiopathy
135. Inhibition of bovine retinal microvascular pericyte proliferation in vitro by adenosine
136. Antiproliferative effect of elevated glucose in human microvascular endothelial cells
137. Hypoxia, endothelium and purines
138. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells
139. Physiological aspects of primary hypertension
140. Endothelial and smooth muscle cell migration in the repair of the injured vessel wall
141. Adenosine may regulate the vascular supply and thus the growth and spread of neoplastic tissues: A proposal
142. Human tumor tissues have higher ATP contents than normal tissues
143. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: Involvement of intracellular calcium and cyclic adenosine monophosphate
144. Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells
145. 1 receptor stimulate mitogen-activated protein kinases and induce apoptosis
146. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase
147. Identification of a novel human ADP receptor coupled to G(i)
148. Identification of the platelet ADP receptor targeted by antithrombotic drugs
149. Development and perspectives of the purinoceptor concept